The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma
Keyword(s):
2017 ◽
Vol 16
(1)
◽
pp. 211
◽
1998 ◽
Vol 23
(4)
◽
pp. 248-253
◽